Fumihiko Matsuno

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

Ben K. Seon, Fumihiko Matsuno, Yuro Haruta et al. · PubMed · 1997 · 167 citations

Endothelial Cells, Immunology, Immunoediting +16

Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.

Norihiko Takahashi, Akinao Haba, Fumihiko Matsuno et al. · PubMed · 2001 · 152 citations

Clinical Immunology, Immunology, Dermatology +20

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.

Fumihiko Matsuno, Yuro Haruta, Masao Kondo et al. · PubMed · 1999 · 145 citations

Cancer Immunosurveillance, Unconjugated Mabs, Immunology +14

Macrophage inflammatory protein‐1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM

Shima Uneda, Hiroyuki Hata, Fumihiko Matsuno et al. · British Journal of Haematology · 2002 · 85 citations

Immunology, Immune Regulation, Pathology +18

Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human

Naoki Morito, Keigyou Yoh, Yuki Fujioka et al. · Cancer Research · 2006 · 78 citations